logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 1 of 1 Items
Showing 1 - 1 of 1 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB

Murphy RA, Douglas-Jones B, Mucinya G, Sunpath H, Govender T
2021-09-01 • International Journal of Tuberculosis and Lung Disease
2021-09-01 • International Journal of Tuberculosis and Lung Disease
The wider availability of dolutegravir (DTG) containing HIV therapy for patients living with multidrug-resistant TB (MDR-TB) presents several advantages. DTG-based antiretroviral therapy...